Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cohn

Showing results (391-400 of 612) with videos related to

Pageof 62
Sort By:
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1996
T cell responses to the paramyxovirus simian virus 5: studies in multiple sclerosis and normal populationsM L Cohn, E D Robinson, D Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Prominent microvascular proliferation in clinically aggressive neuroblastomaRadhika Peddinti, Rana Zeine, Dragos Luca, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|October 5, 2021
Design of Pd-Decorated SrTiO<sub>3</sub>/BiOBr Heterojunction Materials for Enhanced Visible-Light-Based Photocatalytic ReactivityMary O Olagunju, Elsayed M Zahran, Elnaz Zeynaloo, et al.
British Journal of Cancer|April 30, 2009
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task ForceK Beiske, S A Burchill, I Y Cheung, et al.
JCO Clinical Cancer Informatics|December 9, 2021
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk GroupAnoop Mayampurath, Siddhi Ramesh, Diana Michael, et al.
Molecular Cancer|June 8, 2010
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumorsAlexandre Chlenski, Lisa J Guerrero, Radhika Peddinti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
Parental smoking and alcohol consumption and risk of neuroblastomaQ Yang, A F Olshan, M L Bondy, et al.
Pediatric Blood & Cancer|July 24, 2008
Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) projectSteven G Dubois, Wendy B London, Yang Zhang, et al.
Pediatric Blood & Cancer|December 8, 2011
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growthNisha C Kakodkar, Radhika R Peddinti, Yufeng Tian, et al.
The Journal of Pediatrics|November 1, 1994
Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastomaP S Koh, J G Raffensperger, S Berry, et al.
Pageof 62

Showing results (391-400 of 612) with videos related to

Sort By:
Pageof 62
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1996
T cell responses to the paramyxovirus simian virus 5: studies in multiple sclerosis and normal populationsM L Cohn, E D Robinson, D Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Prominent microvascular proliferation in clinically aggressive neuroblastomaRadhika Peddinti, Rana Zeine, Dragos Luca, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|October 5, 2021
Design of Pd-Decorated SrTiO<sub>3</sub>/BiOBr Heterojunction Materials for Enhanced Visible-Light-Based Photocatalytic ReactivityMary O Olagunju, Elsayed M Zahran, Elnaz Zeynaloo, et al.
British Journal of Cancer|April 30, 2009
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task ForceK Beiske, S A Burchill, I Y Cheung, et al.
JCO Clinical Cancer Informatics|December 9, 2021
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk GroupAnoop Mayampurath, Siddhi Ramesh, Diana Michael, et al.
Molecular Cancer|June 8, 2010
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumorsAlexandre Chlenski, Lisa J Guerrero, Radhika Peddinti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
Parental smoking and alcohol consumption and risk of neuroblastomaQ Yang, A F Olshan, M L Bondy, et al.
Pediatric Blood & Cancer|July 24, 2008
Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) projectSteven G Dubois, Wendy B London, Yang Zhang, et al.
Pediatric Blood & Cancer|December 8, 2011
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growthNisha C Kakodkar, Radhika R Peddinti, Yufeng Tian, et al.
The Journal of Pediatrics|November 1, 1994
Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastomaP S Koh, J G Raffensperger, S Berry, et al.
Pageof 62